BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 16920564)

  • 1. Methylenetetrahydrofolate reductase and thymidylate synthase genotypes and risk of acute graft-versus-host disease following hematopoietic cell transplantation for chronic myelogenous leukemia.
    Robien K; Bigler J; Yasui Y; Potter JD; Martin P; Storb R; Ulrich CM
    Biol Blood Marrow Transplant; 2006 Sep; 12(9):973-80. PubMed ID: 16920564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia.
    Robien K; Ulrich CM; Bigler J; Yasui Y; Gooley T; Bruemmer B; Potter JD; Radich JP
    Clin Cancer Res; 2004 Nov; 10(22):7592-8. PubMed ID: 15569990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of methylenetetrahydrofolate reductase (MTHFR 677C>T) and thymidylate synthase (TSER and TS 1494del6) polymorphisms with premature ovarian failure in Korean women.
    Rah H; Jeon YJ; Choi Y; Shim SH; Yoon TK; Choi DH; Cha SH; Kim NK
    Menopause; 2012 Nov; 19(11):1260-6. PubMed ID: 22713864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Donor methylenetetrahydrofolate reductase genotype is associated with graft-versus-host disease in hematopoietic stem cell transplant patients treated with methotrexate.
    Murphy N; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King B; Macgregor L; Holdsworth R; McCluskey J; Tait BD
    Bone Marrow Transplant; 2006 Apr; 37(8):773-9. PubMed ID: 16518429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation in patients with the 5,10-methylenetetrahydrofolate reductase 677TT genotype.
    Sugimoto K; Murata M; Onizuka M; Inamoto Y; Terakura S; Kuwatsuka Y; Oba T; Miyamura K; Kodera Y; Naoe T
    Int J Hematol; 2008 Jun; 87(5):451-458. PubMed ID: 18365141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylenetetrahydrofolate reductase (MTHFR) gene C677T, A1298C and G1793A polymorphisms: association with risk for clear cell renal cell carcinoma and tumour behaviour in men.
    Safarinejad MR; Shafiei N; Safarinejad S
    Clin Oncol (R Coll Radiol); 2012 May; 24(4):269-81. PubMed ID: 21489764
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of combined methylenetetrahydrofolate reductase (MTHFR) and thymidylate synthase enhancer region (TSER) polymorphisms to plasma homocysteine levels in Korean patients with recurrent spontaneous abortion.
    Kim NK; Choi YK; Kang MS; Choi DH; Cha SH; An MO; Lee S; Jeung M; Ko JJ; Oh D
    Thromb Res; 2006; 117(6):653-8. PubMed ID: 15985285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and thymidylate synthase, dietary folate intake, and the risk of leukemia in adults.
    Liu P; Zhang M; Xie X; Jin J; Holman CD
    Tumour Biol; 2016 Mar; 37(3):3265-75. PubMed ID: 26438060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of folinic acid on methylenetetrahydrofolate reductase polymorphisms in methotrexate-treated allogeneic hematopoietic stem cell transplants.
    Murphy NM; Diviney M; Szer J; Bardy P; Grigg A; Hoyt R; King-Kallimanis B; Holdsworth R; McCluskey J; Tait BD
    Biol Blood Marrow Transplant; 2012 May; 18(5):722-30. PubMed ID: 21920473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylenetetrahydrofolate reductase C677T genotypes and clinical outcome following hematopoietic cell transplant.
    Azarpira N; Ramzi M; Aghdaie MH; Daraie M; Geramizadeh B
    Exp Clin Transplant; 2007 Dec; 5(2):693-7. PubMed ID: 18194124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea.
    Moon HW; Kim TY; Oh BR; Min HC; Cho HI; Bang SM; Lee JH; Yoon SS; Lee DS
    Leuk Res; 2007 Sep; 31(9):1213-7. PubMed ID: 17156840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymorphisms of folate pathway enzymes (methylenetetrahydrofolate reductase and thymidylate synthase) and their relationship with thymidylate synthase expression in human astrocytic tumors.
    da Costa DM; de Lima GP; Faria MH; Rabenhorst SH
    DNA Cell Biol; 2012 Jan; 31(1):57-66. PubMed ID: 21848426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MTHFR A1298C and C677T gene polymorphisms and susceptibility to chronic myeloid leukemia in Egypt.
    Aly RM; Taalab MM; Ghazy HF
    Int J Clin Exp Pathol; 2014; 7(5):2571-8. PubMed ID: 24966971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Methylenetetrahydrofolate Reductase C677T Polymorphism on Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation with Methotrexate Prophylaxis.
    Byun JM; Kim HL; Shin DY; Koh Y; Yoon SS; Seong MW; Park SS; Kim JH; Lee YG; Kim I
    PLoS One; 2016; 11(10):e0163998. PubMed ID: 27783703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphisms of the methylenetetrahydrofolate reductase gene and clinical outcomes in HLA-matched sibling allogeneic hematopoietic stem cell transplantation.
    Kim I; Lee KH; Kim JH; Ra EK; Yoon SS; Hong YC; Park SS; Kim CS; Park S; Kim BK
    Ann Hematol; 2007 Jan; 86(1):41-8. PubMed ID: 17028897
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.
    Takehara A; Kawakami K; Ohta N; Oyama K; Ota Y; Oda M; Watanabe G
    Anticancer Res; 2005; 25(6C):4455-61. PubMed ID: 16334126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms of 5,10-methylenetetrahydrofolate reductase and risk of stomach cancer in a Korean population.
    Kim JK; Kim S; Han JH; Kim HJ; Chong SY; Hong SP; Hwang SG; Ahn JY; Cha KY; Oh D; Kim NK
    Anticancer Res; 2005; 25(3B):2249-52. PubMed ID: 16158971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association between methylene-tetrahydrofolate reductase gene polymorphisms and chronic myeloid leukemia].
    Dorgham S; Aberkane M; Boughrara W; Antar Soltan B; Mehalhal N; Touhami H; Sidimansour N; Merad Boudia N; Louhibi L; Boudjema A
    Bull Cancer; 2014 Sep; 101(9):803-7. PubMed ID: 25036376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
    Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.
    Safarinejad MR; Shafiei N; Safarinejad S
    Prostate; 2010 Nov; 70(15):1645-57. PubMed ID: 20564317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.